BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jodeleit H, Winkelmann P, Caesar J, Sterz S, Holdt LM, Beigel F, Stallhofer J, Breiteneicher S, Bartnik E, Leeuw T, Siebeck M, Gropp R. Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells. Dis Model Mech 2021;14:dmm046995. [PMID: 33293281 DOI: 10.1242/dmm.046995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Allanach JR, Hardman BK, Fettig NM, Fan V, Rosen AR, Shanina I, Vorobeychik G, Osborne LC, Horwitz MS. Epstein-Barr virus infection promotes Th1-mediated disease in a humanized immune mouse model of multiple sclerosis.. [DOI: 10.1101/2022.02.23.481716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li S, Feng G, Zhang M, Zhang X, Lu J, Feng C, Zhu F. Oxymatrine attenuates TNBS-induced colinutis in rats through TLR9/Myd88/NF-κB signal pathway. Hum Exp Toxicol 2022;41:9603271221078866. [PMID: 35290143 DOI: 10.1177/09603271221078866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Negi S, Saini S, Tandel N, Sahu K, Mishra RPN, Tyagi RK. Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice. Cells 2021;10:1847. [PMID: 34440615 DOI: 10.3390/cells10081847] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
4 Winkelmann P, Unterweger AL, Khullar D, Beigel F, Koletzko L, Siebeck M, Gropp R. The PI3K pathway as a therapeutic intervention point in inflammatory bowel disease. Immun Inflamm Dis 2021;9:804-18. [PMID: 33942546 DOI: 10.1002/iid3.435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]